Objective: The purpose of this study was to assess the usefulness of Sonazoid-enhanced ultrasonography (US) in the diagnosis of hepatic malignancies in comparison with contrast-enhanced CT findings. Methods: A total of 74 patients with 113 hepatic tumors having or highly suspected of having malignancies were enrolled. These hepatic nodules were diagnosed by typical findings of imaging such as contrast-enhanced CT, dynamic MRI or Sonazoid-enhanced US, tumor markers and histological examinations after surgical resection or biopsy. Results: 108 nodules were diagnosed as malignant tumors (hepatocellular carcinoma: n = 90; metastasis: n = 16; intrahepatic cholangiocarcinoma: n = 2) and the remaining five tumors were diagnosed as benign tumors (dysplastic nodules: n = 5). Sonazoid-enhanced US correctly depicted the presence or absence of tumors in 74 patients, with a sensitivity of 95.4%, an accuracy of 94.7%, and a positive predictive rate of 99%. Contrast-enhanced CT depicted the malignancies with a sensitivity of 85.2%, an accuracy of 82.3%, and a positive predictive rate of 95.8%. There were significant differences between Sonazoid-enhanced US and contrast-enhanced CT for sensitivity and accuracy (both p < 0.05). Conclusion: Sonazoid-enhanced US has a higher sensitivity and accuracy for the diagnosis of hepatic malignancies than contrast-enhanced CT.

Keywords:
Sonazoid, Sonazoid-enhanced ultrasonography, Hepatic malignancies, Defect reperfusion imaging
1.
Wernecke K, Rummeny E, Bongartz G, Vassallo P, Kivelitz D, Wiesmann W, Peters PE, Reers B, Reiser M, Pircher W: Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. Am J Roentgenol 1991;157:731–739.
2.
Clarke MP, Kane RA, Steele G Jr, Hamilton ES, Ravikumar TS, Onik G, Clouse ME: Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors. Surgery 1989;106:849–855.
3.
Tanaka S, Kitamura T, Ohshima A, Umeda K, Okuda S, Ohtani T, Tatsuta M, Yamamoto K: Diagnostic accuracy of ultrasonography for hepatocellular carcinoma. Cancer 1986;58:344–347.
4.
Tanaka S, Kitamura T, Nakanishi K, Okuda S, Kojima J, Fujimoto I: Recent advances in ultrasonographic diagnosis of hepatocellular carcinoma. Cancer 1989;63:1313–1317.
5.
Tanaka S, Kitamura T, Fujita M, Nakahashi K, Okuda S: Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990;154:509–514.
6.
Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS: Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology 1994;190:853–856.
7.
Koito K, Namieno T, Morita K: Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography. AJR Am J Roentgenol 1998;170:157–160.
8.
Fujimoto M, Moriyasu F, Nishikawa K, Nada T, Okuma M: Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR Am J Roentgenol 1994;163:1099–1104.
9.
Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K: Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. Radiology 2001;220:349–356.
10.
Kudo M, Tomita S, Tochio H, Mimura J, Okabe Y, Kashida H, Hirasa M, Ibuki Y, Todo A: Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. AJR Am J Roentgenol 1992;158:65–74.
11.
Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H: Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007;33:318–325.
12.
Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M: Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 2007;42:643–651.
13.
Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, Takahashi S, Inoue T, Hagiwara S, Chung H, Ueshima K, Maekawa K: Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51:61–69.
14.
Kudo M, Okanoue T; Japan Society of Hepatology: Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007;72:2–15.
15.
Minami Y, Kudo M, Chung H, Kawasaki T, Yagyu Y, Shimono T, Shizaki H: Contrast harmonic sonography-guided radiofrequency ablation versus B-mode sonography in hepatocellular carcinoma: prospective randomized control trial. AJR Am J Roentgenol 2007;188:489–494.
16.
Nakamura S, Nouso K, Sakaguchi K, Ito Y, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y: Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Am J Gastroenterol 2006;101:2038–2043.
17.
Tanimoto A, Wakabayashi G, Shinmoto H, Nakatsuka S, Okuda S, Kuribayashi S: Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography. J Gastroenterol 2005;40:371–380.
18.
Kanematsu M, Hoshi H, Murakami T, lnaba Y, Kim T, Yamada T, Kato M, Yokoyama R, Nakamura H: Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. AJR Am J Roentgenol 1997;169:1507–1515.
19.
Sontum PC, Ostensen J, Dyrstad K, Hoff L: Acoustic properties of NC100100 and their relation with the microbubble size distribution. Invest Radiol 1999;34:268–275.
20.
Kudo M, Hatanaka K, Chung H, Minami Y, Maekawa K: A proposal of novel treatment-assist technique in the Sonazoid-enhanced ultrasonography: value of defect re-perfusion imaging. Acta Hepatol Jpn 2007;48:299–301.
21.
Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, Claudon M, Calliada F, Correas JM, LaFortune M, Campani R, Hoffmann CW, Cosgrove DO, LeFevre F: Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003;227:361–370.
22.
D’Onofrio M, Martone E, Faccioli N, Zamboni G, Malagò R, Mucelli RP: Focal liver lesions: sinusoidal phase of CEUS. Abdom Imaging 2006;31:529–536.
23.
Rabenandrasana HA, Furukawa A, Furuichi K, Yamasaki M, Takahashi M, Murata K: Comparison between tissue harmonic imaging and liver-specific late-phase contrast-enhanced pulse-inversion imaging in the detection of hepatocellular carcinoma and liver metastasis. Radiat Med 2004;22:90–97.
24.
Isozaki T, Numata K, Kiba T, Hara K, Morimoto M, Sakaguchi T, Sekihara H, Kubota T, Shimada H, Morizane T, Tanaka K: Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003;229:798–805.
25.
Wang JH, Lu SN, Hung CH, Chen TY, Chen CH, Changchien CS, Lee CM: Small hepatic nodules (<2 cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonography. Liver Int 2006;26:928–934.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.